Meningioma Clinical Trials in Columbus, Ohio

4 studies are recruiting for meningioma in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

    The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    The Ohio State University College of Medicine (OSUCOM), Columbus, Ohio
    Locations
    17 in total
    Run by
    Exelixis

    See if you can join NCT07428616 on ClinicalTrials.gov

  2. Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

    This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS) tumors and meningiomas that demonstrate uptake on DOTATATE PET. The drug will be given intravenously once every 8 weeks for a total of up …

    Stage
    Phase 1
    Ages
    4 to 39
    Site
    Nationwide Children's Hospital, Columbus, Ohio
    Locations
    4 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05278208 on ClinicalTrials.gov

  3. Cognitive Status After Removal of Skull Base Meningioma

    The purpose of this prospectively enrolling trial is to assess long-term cognitive outcomes of patients undergoing surgery for resection of a meningioma associated with the frontal and temporal lobes.

    Stage
    Not phased
    Ages
    18 to 89
    Site
    Ohio State University Wexner Medical Center, Columbus, Ohio
    Run by
    Ohio State University

    See if you can join NCT04635657 on ClinicalTrials.gov

  4. Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

    This study is Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors

    Stage
    Phase 1
    Ages
    18 to 90
    Site
    Ohio State University, Columbus, Ohio
    Locations
    19 in total
    Run by
    Perspective Therapeutics

    See if you can join NCT05636618 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.